Global Cancer Biological Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2030

Report ID: IBI1595325 | Category: Medical Care | Pages: 130 | Format: PDF | Published Date: August 16,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3550.00 Multi User-$4550.00

Report Description
View Table of Contents

Report Summary

The Cancer Biological Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Cancer Biological Therapy size is estimated to be USD xx million in 2030 from USD xx million in 2019, with a change XX% between 2019 and 2023. The global Cancer Biological Therapy market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Cancer Biological Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Monoclonal Antibodies
    Vaccines
    Cancer Growth Blockers
    Blood Cell Growth Factors

Market segment by Application, can be divided into
    Hospitals
    Diagnostic Laboratories
    Research & Academic Laboratories
    Pharmaceutical & Biotechnology Companies

Market segment by players, this report covers
    ELI Lilly
    Sanofi
    Merck
    Bayer
    Roche
    Novartis International
    Pfizer
    Bristol-Myers Squibb
    Seattle Genetics
    Amgen
    Takeda Pharmaceuticals
    GlaxoSmithKline
    Spectrum Pharmaceuticals
    Celgene Corporation
    AstraZeneca, Plc.
    Otsuka
    Eisai
    Abbvie
    Incyte

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Cancer Biological Therapy product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Cancer Biological Therapy, with revenue, gross margin and global market share of Cancer Biological Therapy from 2019 to 2023.
Chapter 3, the Cancer Biological Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2023.and Cancer Biological Therapy market forecast, by regions, type and application, with revenue, from 2023 to 2030.
Chapter 11 and 12, to describe Cancer Biological Therapy research findings and conclusion, appendix and data source.

1 Market Overview
    1.1 Product Overview and Scope of Cancer Biological Therapy
    1.2 Classification of Cancer Biological Therapy by Type
        1.2.1 Overview: Global Cancer Biological Therapy Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Cancer Biological Therapy Revenue Market Share by Type in 2020
        1.2.3 Monoclonal Antibodies
        1.2.4 Vaccines
        1.2.5 Cancer Growth Blockers
        1.2.6 Blood Cell Growth Factors
    1.3 Global Cancer Biological Therapy Market by Application
        1.3.1 Overview: Global Cancer Biological Therapy Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Hospitals
        1.3.3 Diagnostic Laboratories
        1.3.4 Research & Academic Laboratories
        1.3.5 Pharmaceutical & Biotechnology Companies
    1.4 Global Cancer Biological Therapy Market Size & Forecast
    1.5 Global Cancer Biological Therapy Market Size and Forecast by Region
        1.5.1 Global Cancer Biological Therapy Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Cancer Biological Therapy Market Size by Region, (2016-2021)
        1.5.3 North America Cancer Biological Therapy Market Size and Prospect (2019-2030)
        1.5.4 Europe Cancer Biological Therapy Market Size and Prospect (2019-2030)
        1.5.5 Asia-Pacific Cancer Biological Therapy Market Size and Prospect (2019-2030)
        1.5.6 South America Cancer Biological Therapy Market Size and Prospect (2019-2030)
        1.5.7 Middle East and Africa Cancer Biological Therapy Market Size and Prospect (2019-2030)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Cancer Biological Therapy Market Drivers
        1.6.2 Cancer Biological Therapy Market Restraints
        1.6.3 Cancer Biological Therapy Trends Analysis
2 Company Profiles
    2.1 ELI Lilly
        2.1.1 ELI Lilly Details
        2.1.2 ELI Lilly Major Business
        2.1.3 ELI Lilly Cancer Biological Therapy Product and Solutions
        2.1.4 ELI Lilly Cancer Biological Therapy Revenue, Gross Margin and Market Share (2021-2023)
        2.1.5 ELI Lilly Recent Developments and Future Plans
    2.2 Sanofi
        2.2.1 Sanofi Details
        2.2.2 Sanofi Major Business
        2.2.3 Sanofi Cancer Biological Therapy Product and Solutions
        2.2.4 Sanofi Cancer Biological Therapy Revenue, Gross Margin and Market Share (2021-2023)
        2.2.5 Sanofi Recent Developments and Future Plans
    2.3 Merck
        2.3.1 Merck Details
        2.3.2 Merck Major Business
        2.3.3 Merck Cancer Biological Therapy Product and Solutions
        2.3.4 Merck Cancer Biological Therapy Revenue, Gross Margin and Market Share (2021-2023)
        2.3.5 Merck Recent Developments and Future Plans
    2.4 Bayer
        2.4.1 Bayer Details
        2.4.2 Bayer Major Business
        2.4.3 Bayer Cancer Biological Therapy Product and Solutions
        2.4.4 Bayer Cancer Biological Therapy Revenue, Gross Margin and Market Share (2021-2023)
        2.4.5 Bayer Recent Developments and Future Plans
    2.5 Roche
        2.5.1 Roche Details
        2.5.2 Roche Major Business
        2.5.3 Roche Cancer Biological Therapy Product and Solutions
        2.5.4 Roche Cancer Biological Therapy Revenue, Gross Margin and Market Share (2021-2023)
        2.5.5 Roche Recent Developments and Future Plans
    2.6 Novartis International
        2.6.1 Novartis International Details
        2.6.2 Novartis International Major Business
        2.6.3 Novartis International Cancer Biological Therapy Product and Solutions
        2.6.4 Novartis International Cancer Biological Therapy Revenue, Gross Margin and Market Share (2021-2023)
        2.6.5 Novartis International Recent Developments and Future Plans
    2.7 Pfizer
        2.7.1 Pfizer Details
        2.7.2 Pfizer Major Business
        2.7.3 Pfizer Cancer Biological Therapy Product and Solutions
        2.7.4 Pfizer Cancer Biological Therapy Revenue, Gross Margin and Market Share (2021-2023)
        2.7.5 Pfizer Recent Developments and Future Plans
    2.8 Bristol-Myers Squibb
        2.8.1 Bristol-Myers Squibb Details
        2.8.2 Bristol-Myers Squibb Major Business
        2.8.3 Bristol-Myers Squibb Cancer Biological Therapy Product and Solutions
        2.8.4 Bristol-Myers Squibb Cancer Biological Therapy Revenue, Gross Margin and Market Share (2021-2023)
        2.8.5 Bristol-Myers Squibb Recent Developments and Future Plans
    2.9 Seattle Genetics
        2.9.1 Seattle Genetics Details
        2.9.2 Seattle Genetics Major Business
        2.9.3 Seattle Genetics Cancer Biological Therapy Product and Solutions
        2.9.4 Seattle Genetics Cancer Biological Therapy Revenue, Gross Margin and Market Share (2021-2023)
        2.9.5 Seattle Genetics Recent Developments and Future Plans
    2.10 Amgen 
        2.10.1 Amgen Details
        2.10.2 Amgen Major Business
        2.10.3 Amgen Cancer Biological Therapy Product and Solutions
        2.10.4 Amgen Cancer Biological Therapy Revenue, Gross Margin and Market Share (2021-2023)
        2.10.5 Amgen Recent Developments and Future Plans
    2.11 Takeda Pharmaceuticals
        2.11.1 Takeda Pharmaceuticals Details
        2.11.2 Takeda Pharmaceuticals Major Business
        2.11.3 Takeda Pharmaceuticals Cancer Biological Therapy Product and Solutions
        2.11.4 Takeda Pharmaceuticals Cancer Biological Therapy Revenue, Gross Margin and Market Share (2021-2023)
        2.11.5 Takeda Pharmaceuticals Recent Developments and Future Plans
    2.12 GlaxoSmithKline
        2.12.1 GlaxoSmithKline Details
        2.12.2 GlaxoSmithKline Major Business
        2.12.3 GlaxoSmithKline Cancer Biological Therapy Product and Solutions
        2.12.4 GlaxoSmithKline Cancer Biological Therapy Revenue, Gross Margin and Market Share (2021-2023)
        2.12.5 GlaxoSmithKline Recent Developments and Future Plans
    2.13 Spectrum Pharmaceuticals
        2.13.1 Spectrum Pharmaceuticals Details
        2.13.2 Spectrum Pharmaceuticals Major Business
        2.13.3 Spectrum Pharmaceuticals Cancer Biological Therapy Product and Solutions
        2.13.4 Spectrum Pharmaceuticals Cancer Biological Therapy Revenue, Gross Margin and Market Share (2021-2023)
        2.13.5 Spectrum Pharmaceuticals Recent Developments and Future Plans
    2.14 Celgene Corporation
        2.14.1 Celgene Corporation Details
        2.14.2 Celgene Corporation Major Business
        2.14.3 Celgene Corporation Cancer Biological Therapy Product and Solutions
        2.14.4 Celgene Corporation Cancer Biological Therapy Revenue, Gross Margin and Market Share (2021-2023)
        2.14.5 Celgene Corporation Recent Developments and Future Plans
    2.15 AstraZeneca, Plc.
        2.15.1 AstraZeneca, Plc. Details
        2.15.2 AstraZeneca, Plc. Major Business
        2.15.3 AstraZeneca, Plc. Cancer Biological Therapy Product and Solutions
        2.15.4 AstraZeneca, Plc. Cancer Biological Therapy Revenue, Gross Margin and Market Share (2021-2023)
        2.15.5 AstraZeneca, Plc. Recent Developments and Future Plans
    2.16 Otsuka
        2.16.1 Otsuka Details
        2.16.2 Otsuka Major Business
        2.16.3 Otsuka Cancer Biological Therapy Product and Solutions
        2.16.4 Otsuka Cancer Biological Therapy Revenue, Gross Margin and Market Share (2021-2023)
        2.16.5 Otsuka Recent Developments and Future Plans
    2.17 Eisai
        2.17.1 Eisai Details
        2.17.2 Eisai Major Business
        2.17.3 Eisai Cancer Biological Therapy Product and Solutions
        2.17.4 Eisai Cancer Biological Therapy Revenue, Gross Margin and Market Share (2021-2023)
        2.17.5 Eisai Recent Developments and Future Plans
    2.18 Abbvie
        2.18.1 Abbvie Details
        2.18.2 Abbvie Major Business
        2.18.3 Abbvie Cancer Biological Therapy Product and Solutions
        2.18.4 Abbvie Cancer Biological Therapy Revenue, Gross Margin and Market Share (2021-2023)
        2.18.5 Abbvie Recent Developments and Future Plans
    2.19 Incyte
        2.19.1 Incyte Details
        2.19.2 Incyte Major Business
        2.19.3 Incyte Cancer Biological Therapy Product and Solutions
        2.19.4 Incyte Cancer Biological Therapy Revenue, Gross Margin and Market Share (2021-2023)
        2.19.5 Incyte Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Cancer Biological Therapy Revenue and Share by Players (2021-2023)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Cancer Biological Therapy Players Market Share
        3.2.2 Top 10 Cancer Biological Therapy Players Market Share
        3.2.3 Market Competition Trend
    3.3 Cancer Biological Therapy Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Cancer Biological Therapy Revenue and Market Share by Type (2016-2021)
    4.2 Global Cancer Biological Therapy Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
    5.1 Global Cancer Biological Therapy Revenue Market Share by Application (2016-2021)
    5.2 Cancer Biological Therapy Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
    6.1 North America Cancer Biological Therapy Revenue by Type (2019-2030)
    6.2 North America Cancer Biological Therapy Revenue by Application (2019-2030)
    6.3 North America Cancer Biological Therapy Market Size by Country
        6.3.1 North America Cancer Biological Therapy Revenue by Country (2019-2030)
        6.3.2 United States Cancer Biological Therapy Market Size and Forecast (2019-2030)
        6.3.3 Canada Cancer Biological Therapy Market Size and Forecast (2019-2030)
        6.3.4 Mexico Cancer Biological Therapy Market Size and Forecast (2019-2030)
7 Europe by Country, by Type, and by Application
    7.1 Europe Cancer Biological Therapy Revenue by Type (2019-2030)
    7.2 Europe Cancer Biological Therapy Revenue by Application (2019-2030)
    7.3 Europe Cancer Biological Therapy Market Size by Country
        7.3.1 Europe Cancer Biological Therapy Revenue by Country (2019-2030)
        7.3.2 Germany Cancer Biological Therapy Market Size and Forecast (2019-2030)
        7.3.3 France Cancer Biological Therapy Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Cancer Biological Therapy Market Size and Forecast (2019-2030)
        7.3.5 Russia Cancer Biological Therapy Market Size and Forecast (2019-2030)
        7.3.6 Italy Cancer Biological Therapy Market Size and Forecast (2019-2030)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Cancer Biological Therapy Revenue by Type (2019-2030)
    8.2 Asia-Pacific Cancer Biological Therapy Revenue by Application (2019-2030)
    8.3 Asia-Pacific Cancer Biological Therapy Market Size by Region
        8.3.1 Asia-Pacific Cancer Biological Therapy Revenue by Region (2019-2030)
        8.3.2 China Cancer Biological Therapy Market Size and Forecast (2019-2030)
        8.3.3 Japan Cancer Biological Therapy Market Size and Forecast (2019-2030)
        8.3.4 South Korea Cancer Biological Therapy Market Size and Forecast (2019-2030)
        8.3.5 India Cancer Biological Therapy Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Cancer Biological Therapy Market Size and Forecast (2019-2030)
        8.3.7 Australia Cancer Biological Therapy Market Size and Forecast (2019-2030)
9 South America by Country, by Type, and by Application
    9.1 South America Cancer Biological Therapy Revenue by Type (2019-2030)
    9.2 South America Cancer Biological Therapy Revenue by Application (2019-2030)
    9.3 South America Cancer Biological Therapy Market Size by Country
        9.3.1 South America Cancer Biological Therapy Revenue by Country (2019-2030)
        9.3.2 Brazil Cancer Biological Therapy Market Size and Forecast (2019-2030)
        9.3.3 Argentina Cancer Biological Therapy Market Size and Forecast (2019-2030)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Cancer Biological Therapy Revenue by Type (2019-2030)
    10.2 Middle East & Africa Cancer Biological Therapy Revenue by Application (2019-2030)
    10.3 Middle East & Africa Cancer Biological Therapy Market Size by Country
        10.3.1 Middle East & Africa Cancer Biological Therapy Revenue by Country (2019-2030)
        10.3.2 Turkey Cancer Biological Therapy Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Cancer Biological Therapy Market Size and Forecast (2019-2030)
        10.3.4 UAE Cancer Biological Therapy Market Size and Forecast (2019-2030)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Cancer Biological Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2030

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?